Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week study
Abstract Background Roxadustat is an oral hypoxia inducing factor-prolyl hydroxylase inhibitor (HIF-PHI) that regulates iron metabolism in patients with chronic kidney disease (CKD) primarily by reducing hepcidin levels and mobilizing internal iron stores. More data are needed to demonstrate the eff...
| Автори: | , , , , , , |
|---|---|
| Формат: | Стаття |
| Мова: | English |
| Опубліковано: |
BMC
2023-11-01
|
| Серія: | European Journal of Medical Research |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s40001-023-01465-0 |